Results 211 to 220 of about 12,986,553 (373)

Association of Anti–Factor Xa–Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma

JAMA Surgery, 2017
Charles A. Karcutskie, A. Dharmaraja, J. Patel, Sarah A. Eidelson, Anish B. Padiadpu, Arch G Martin, G. Lama, Edward B. Lineen, N. Namias, C. Schulman, K. Proctor   +10 more
semanticscholar   +1 more source

Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID

Immunology, EarlyView.
The complement cascade, a series of blood proteins that assists in the recognition and neutralisation of pathogens, either independently or in conjunction with antibodies, is persistently activated in patients with long COVID. We found that blood plasma samples from patients with long COVID contained elevated concentrations of the mannan‐binding lectin‐
Samuel B. K. Keat, Priyanka Khatri, Youssif M. Ali, Chanuka H. Arachchilage, Gregory Demopulos, Kirsten Baillie, Kelly L. Miners, Kristin Ladell, Samantha A. Jones, Helen E. Davies, David A. Price, Wioleta M. Zelek, B. Paul Morgan, Wilhelm J. Schwaeble, Nicholas J. Lynch   +14 more
wiley   +1 more source

Predictors of hematoma expansion in intracerebral hemorrhage associated with factor Xa inhibitors. [PDF]

Front Neurol
Komatsu Y, Koiso T, Sekine T, Akutagawa K, Karita H, Kikuchi N, Yamazaki T.   +6 more
europepmc   +1 more source

Freight distribution optimization by implementing the team orienteering problem with occasional drivers

International Transactions in Operational Research, EarlyView.
Abstract This research evaluates the effectiveness of a hybrid crowdshipping system that integrates occasional drivers with traditional delivery services (OD+TD) to improve the efficiency of freight distribution. By implementing the team orienteering problem with occasional drivers model, we develop a mathematical model and an agile optimization ...
Alisson Garcia‐Herrera, Xabier A. Martin, Adrian Serrano‐Hernandez, Angel A. Juan, Javier Faulin   +4 more
wiley   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source

Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors. [PDF]

Blood Adv
Rea J, Lee C, Kee M, Rucker B, Flores H, Walters C, Haney T, Tomlin A, Khan A, Vassar M.   +9 more
europepmc   +1 more source

Properties of the factor Xa binding site on human platelets.

, 1978
Joseph P. Miletich, Craig M. Jackson, Philip W. Majerus   +2 more
openalex   +1 more source

Cauda equina syndrome due to Factor Xa inhibitor (Rivaroxaban): Case report and review of literature

, 2020
SR Gowda, PJ O’Hagan, JT Griffiths
openalex   +2 more sources

Anti Factor Xa Activity In Plasma Following Oral, Pulmonary, Subcutaneous And Intravenous Administration Of Cd5000 Low Molecular Weight Heparin And Commercial Heparin To Rats, Rabbits And Dogs [PDF]

, 1981
Lester I. Harrison, Colin R. Kehe, R. Ober   +2 more
openalex   +1 more source

Comparison of outcomes in patients with intracranial hemorrhage on factor Xa inhibitors versus vitamin K antagonists treated with 4-factor prothrombin complex concentrate

Proceedings, 2018
Sarah Harrison, J. Garrett, Kelsey N Kohman, J. Kline   +3 more
semanticscholar   +1 more source